Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease

• Главные авторы: Joel N. Maslow (Автор), Jackie J. Kwon (Автор), Susan K. Mikota (Автор), Susan Spruill (Автор), Youngran Cho (Автор), Moonsup Jeong (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2019-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea although retrospective studies have documented seropre...